BATS BZX Real-Time Price
As of 3:35pm ET
| -0.57 / -10.46%|
The 3 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 10.00. The median estimate represents a +125.41% increase from the last price of 4.88.
The current consensus among 8 polled investment analysts is to Hold stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.